CAPR DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

Rosen Law Firm announces securities class action lawsuits against multiple companies, including Capricor Therapeutics, for allegedly making materially false statements. Capricor is accused of failing to disclose changes to statistical analysis plans for its Deramiocel cell therapy and FDA concerns regarding regulatory approval for Duchenne muscular dystrophy treatment. Investors with losses exceeding $100K are encouraged to join the class action before the September 28, 2026 deadline.